Robert Patrick Beecroft, Director at ImmunoPrecise Antibodies, holds 4.33M shares in ImmunoPrecise Antibodies (Ticker: IPA). Most recently, Robert Patrick Beecroft Sold $500,000 shares of ImmunoPrecise Antibodies on Nov 14, 2018 for an estimated value of 415.00K.